These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8131365)

  • 1. Clinical trials of synthetic surfactant in the respiratory distress syndrome of premature infants.
    Corbet A
    Clin Perinatol; 1993 Dec; 20(4):737-60. PubMed ID: 8131365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials of natural surfactant extract in respiratory distress syndrome.
    Mercier CE; Soll RF
    Clin Perinatol; 1993 Dec; 20(4):711-35. PubMed ID: 8131364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant for premature infants with respiratory distress.
    Med Lett Drugs Ther; 1990 Jan; 32(809):2-3. PubMed ID: 2294387
    [No Abstract]   [Full Text] [Related]  

  • 4. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome.
    Reynolds MS; Wallander KA
    Clin Pharm; 1989 Aug; 8(8):559-76. PubMed ID: 2670398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Investigational New Drug experience with Survanta (beractant).
    Zola EM; Overbach AM; Gunkel JH; Mitchell BR; Nagle BT; DeMarco NG; Henwood GA; Gold AJ
    Pediatrics; 1993 Mar; 91(3):546-51. PubMed ID: 8441557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate surfactant usage in 1996.
    Soll RF
    Eur J Pediatr; 1996 Aug; 155 Suppl 2():S8-13. PubMed ID: 8839739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lucinactant: a novel synthetic surfactant for the treatment of respiratory distress syndrome.
    Donn SM
    Expert Opin Investig Drugs; 2005 Mar; 14(3):329-34. PubMed ID: 15833063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surfactant to premature neonates].
    Jacobsen T; Verder H
    Ugeskr Laeger; 1991 Jul; 153(31):2166-9. PubMed ID: 1866827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of natural surfactants to prevent and treat respiratory distress syndrome.
    Spafford PS; Kendig JW; Maniscalco WM
    Semin Perinatol; 1993 Aug; 17(4):285-94. PubMed ID: 8140443
    [No Abstract]   [Full Text] [Related]  

  • 12. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies: synthetic or natural surfactant treatment for respiratory distress syndrome? The case for synthetic surfactant.
    Whitelaw A
    J Perinat Med; 1996; 24(5):427-35. PubMed ID: 8950722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up on infants treated with porcine surfactant replacement for severe neonatal and infant respiratory distress syndrome: antigenic reactivity evaluation.
    Marraro G; Foresti B; Casiraghi G; Monici Preti P
    Drugs Exp Clin Res; 1991; 17(10-11):511-5. PubMed ID: 1841041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal-derived surfactant treatment of respiratory distress syndrome in premature neonates: a review.
    Fujii AM; Carillo M
    Drugs Today (Barc); 2009 Sep; 45(9):697-709. PubMed ID: 19956811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary surfactant therapy.
    Poulain FR; Clements JA
    West J Med; 1995 Jan; 162(1):43-50. PubMed ID: 7863656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choosing a right surfactant for respiratory distress syndrome treatment.
    Ramanathan R
    Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant treatment for premature babies--a review of clinical trials.
    Morley CJ
    Arch Dis Child; 1991 Apr; 66(4 Spec No):445-50. PubMed ID: 2025043
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials of surfactant replacement in Europe.
    Halliday HL
    Biol Neonate; 1997; 71 Suppl 1():8-12. PubMed ID: 9209742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.